In this issue of Pro Te (Volume 11, No.3), we examine three important topics that are sure to capture your interest.
The Supreme Court’s Bristol-Meyers Squibb decision was met with no small amount of (completely justified)...more
12/5/2018
/ Actual Damages ,
Advertising ,
Bristol-Myers Squibb ,
Bristol-Myers Squibb Co v Superior Court of California - San Francisco County ,
Cosmetics ,
Damage Caps ,
FDA Approval ,
Personal Jurisdiction ,
Pharmaceutical Industry ,
Product Labels ,
Wrongful Death
In this issue of Pro Te (Volume 11, No.2), we examine three important topics with practical implications.
In many jurisdictions, the medical judgment of physicians is almost sacrosanct – at least insofar as it is...more
9/21/2018
/ 21st Century Cures Act ,
Dismissal With Prejudice ,
FDA Approval ,
Food and Drug Administration (FDA) ,
Medical Devices ,
New Guidance ,
Patients ,
Pharmaceutical Industry ,
Physicians ,
Prescription Drugs ,
Regulatory Oversight ,
Statute of Limitations